
Overview
Aflofarm Farmacja Polska is a Polish pharmaceutical company that has operated in healthcare for 30 years and has led Poland’s over-the-counter market since 2012, with brands such as Desmoxan, Neosine and Dafurag. Its portfolio includes more than 180 brands, including prescription and OTC medicines, medical devices, cosmetics and dietary supplements; the company employs over 1,500 people and exports products to 31 countries.
Financials
Revenue history (in m)
From the notes
| Current income tax (CIT due) | $13,469,923 |
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 89 days late). All were audited by a statutory auditor.
- 202508/07/2026
- 202410/07/2025
- 202310/07/2024
- 202204/07/2023
- 202112/10/2022
- 202013/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Offer
Websites
The site is available in: English and Russian.
- aflofarm.com.plAflofarmGoogle Tag ManagerApache
Public procurement
No recorded participation in tenders.
The company is the contractor in one public sector contract, worth USD 430.82.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Oct 5, 2026 | Purchase and delivery of medicines | $430.82 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Ministerstwa Spraw Wewnętrznych I Administracji w Koszalinie |
Trademarks
The company holds 472 active trademarks registered with the Polish Patent Office. 34 applications are pending. 326 marks have expired or were not registered. The first mark was filed in 1988.
| Mark | Protected until | |
|---|---|---|
| osegrypin (word) | Mar 12, 2036 | |
| osemivir (word) | Mar 12, 2036 | |
| ibusimplic (word) | Feb 16, 2036 | |
| more (word) | Jan 30, 2036 | |
| ASECURIN (word) | Dec 2, 2035 |
Job offers
The company has its own careers page: aflofarm.com.pl/pl/kariera.
Authorized Representatives
Manner of representation
For making declarations of will on behalf of the company with respect to both property and non-property rights and obligations, and for signing on its behalf, two members of the management board or a member of the management board jointly with a commercial proxy are authorized.
Supervisory board
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Andrzej Zbigniew Furman age 75 | 138,719 | $2,341,960.43 | 33.0013% |
Jacek Furman age 51 | 126,097 | $2,128,866.15 | 29.9985% |
Wojciech Maciej Furman age 47 | 126,097 | $2,128,866.15 | 29.9985% |
Others | 29,431 | $496,876.69 | 7.0017% |
Andrzej Zbigniew Furman, Jacek Furman and Wojciech Maciej Furman hold a combined 93% – the ownership structure indicates family control.
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Trec Nutrition sp. z o.o. | 18,165.86 USD | 100% |
Bank accounts
Registered as a VAT taxpayer on 2003-11-01.
31 1440 1101 0000 0000 1616 7916
23 1500 1546 1215 4004 1343 0000
19 1500 1546 1215 4006 5310 0000
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $1.1M$1,084,493 |
Buildings and premises | $21.2M$21,150,763 |
Public aid
17 public aid cases recorded, with a total value of $11,836,574.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 30, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $0$0 | Małopolska Agencja Rozwoju Regionalnego S.A. | |
| Oct 30, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $0$0 | Instytut Nauk Społeczno-Ekonomicznych sp. z o.o. + limited partnership | |
| Jun 30, 2023 | Regional investment aid | $1.4M$1,402,939 | PIERWSZY MAZOWIECKI URZĄD SKARBOWY W WARSZAWIE |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2019-06-01 | Expansion of Aflofarm's research and development facilities to increase R&D activity in the development of new medicinal products, medical devices and cosmetics | $725.7K$725,719 | Regional Operational Programme of the Łódź Voivodeship for 2014–2020 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| Waste generation | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Adamed Pharma S.A. | $541,927,181.76 | adamed.com.pl | ||
| Bausch Health Poland sp. z o.o. | $433,316,311.35 | bauschhealthpoland.pl | ||
| USP Zdrowie sp. z o.o. | $377,149,656.94 | uspzdrowie.pl | ||
| Biofarm sp. z o.o. | $143,422,260.45 | biofarm.pl | ||
| Zentiva Polska sp. z o.o. | $134,295,523.17 | zentiva.pl | ||
| Angelini Pharma Polska sp. z o.o. | $119,629,315.69 | angelinipharma.pl | ||
| Farmak International sp. z o.o. | $101,647,142.16 | farmakinternational.pl | ||
| Synoptis Pharma sp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| Polfarmex S.A. | $73,543,379.32 | polfarmex.pl | ||
| SUN-Farm sp. z o.o. | $51,063,341.52 | sunfarm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2012-10-25 | Share capital increase (13,100,000.00 PLN → 26,271,500.00 PLN) | |
| 2002-01-22 | Share capital increase (50,000.00 PLN → 13,100,000.00 PLN) | |
| 2001-09-06 | Name change (Aflo Farmacja Polska → Aflofarm Farmacja Polska) | |
| 2001-05-23 | Entered in the register |
FAQ
Last updated: 2026-07-15